BeOne Medicines AG

OTCPK:BEIG.F Stock Report

Market Cap: US$38.4b

BeOne Medicines Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:BEIG.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Feb 26BuyUS$27,382,569JPMorgan Chase & Co.Company1,043,793US$26.23
16 Jan 26BuyUS$746,288JPMorgan Chase & Co.Company28,691US$26.01
16 Jan 26SellUS$3,043JPMorgan Chase & Co.Company117US$26.01
16 Jan 26SellUS$43,529,376JPMorgan Chase & Co.Company1,673,484US$26.01
15 Jan 26BuyUS$938,717JPMorgan Chase & Co.Company35,574US$26.39
15 Jan 26BuyUS$40,931,728JPMorgan Chase & Co.Company1,551,166US$26.39
15 Jan 26SellUS$5,048,683JPMorgan Chase & Co.Company191,327US$26.39
14 Jan 26BuyUS$245,091JPMorgan Chase & Co.Company9,254US$26.48
14 Jan 26BuyUS$4,445,648JPMorgan Chase & Co.Company167,856US$26.48
14 Jan 26SellUS$103,291JP Morgan Asset ManagementCompany3,900US$26.48
14 Jan 26SellUS$129,458JPMorgan Chase & Co.Company4,888US$26.48
14 Jan 26SellUS$51,296,731JPMorgan Chase & Co.Company1,936,830US$26.48
12 Jun 25BuyUS$1,944JP Morgan Asset ManagementCompany91US$21.37
12 Jun 25BuyUS$13,332JPMorgan Chase & Co.Company624US$21.37
12 Jun 25BuyUS$23,747,222JPMorgan Chase & Co.Company1,111,477US$21.37
12 Jun 25SellUS$79,159JPMorgan Chase & Co.Company3,705US$21.37
10 Jun 25BuyUS$10,916JP Morgan Asset ManagementCompany535US$20.40
10 Jun 25BuyUS$1,037,979JPMorgan Chase & Co.Company50,872US$20.40
10 Jun 25BuyUS$4,782,675JPMorgan Chase & Co.Company234,402US$20.40
10 Jun 25SellUS$658,775JPMorgan Chase & Co.Company32,287US$20.40
10 Jun 25SellUS$5,987,475JPMorgan Chase & Co.Company293,450US$20.40
10 Jun 25SellUS$26555I, LLCCompany13US$20.40
09 Jun 25BuyUS$682,151JPMorgan Chase & Co.Company33,241US$20.52
09 Jun 25BuyUS$17,121,309JPMorgan Chase & Co.Company834,316US$20.52
09 Jun 25SellUS$166,223JP Morgan Asset ManagementCompany8,100US$20.52
06 Jun 25BuyUS$1,276JP Morgan Asset ManagementCompany65US$19.64
06 Jun 25BuyUS$608,515JPMorgan Chase & Co.Company30,987US$19.64
06 Jun 25BuyUS$4,228,068JPMorgan Chase & Co.Company215,303US$19.64
06 Jun 25BuyUS$25555I, LLCCompany13US$19.64
06 Jun 25SellUS$140,410JPMorgan Chase & Co.Company7,150US$19.64
06 Jun 25SellUS$19,289,579JPMorgan Chase & Co.Company982,270US$19.64
05 Jun 25BuyUS$7,349,601JPMorgan Chase & Co.Company372,469US$19.73
09 May 25SellUS$267,424,704Hillhouse Investment Management, Ltd.Company16,000,000US$16.71
06 May 25SellUS$28,407,988JPMorgan Chase & Co.Company1,429,758US$19.87
30 Apr 25BuyUS$4,240,131JPMorgan Chase & Co.Company208,451US$20.34
07 Apr 25SellUS$54,205,225JPMorgan Chase & Co.Company3,203,535US$16.92
14 Mar 25SellUS$119,081,388JPMorgan Chase & Co.Company6,122,341US$19.45
04 Mar 25SellUS$2,073,822Xiaodong WangIndividual105,898US$19.58
03 Mar 25BuyUS$120,264,479JPMorgan Chase & Co.Company5,840,467US$20.59

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BEIG.F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies368,3850.333%
Individual Insiders4,830,7794.37%
Hedge Funds8,799,0537.95%
Public Companies18,938,11917.1%
General Public31,353,70328.3%
Institutions46,334,70641.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 61.64% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.1%
Amgen Inc.
18,938,119US$6.6b0%no data
7.95%
Baker Bros. Advisors LP
8,799,053US$3.1b0%16.98%
5.1%
Capital Research and Management Company
5,645,361US$2.0b0.92%0.08%
4.77%
Hillhouse Investment Management, Ltd.
5,271,893US$1.8b0%8.38%
4.59%
PRIMECAP Management Company
5,080,461US$1.8b-0.15%1.15%
3.49%
John Oyler
3,858,922US$1.3b-4.4%no data
3.4%
FMR LLC
3,760,166US$1.3b9.7%0.07%
2.92%
BlackRock, Inc.
3,231,219US$1.1b3.6%0.01%
2.4%
The Vanguard Group, Inc.
2,651,474US$920.3m1.29%0.01%
2.04%
T. Rowe Price Group, Inc.
2,255,581US$782.9m-4.77%0.07%
1.34%
Norges Bank Investment Management
1,485,346US$515.6m0%0.03%
0.91%
Temasek Holdings (Private) Limited
1,011,464US$351.1m0.1%0.22%
0.71%
ICBC Credit Suisse Fund Management Co., Ltd
785,080US$272.5m0%1.42%
0.66%
GF Fund Management Co., Ltd.
728,313US$252.8m-0.01%0.73%
0.65%
Xiaodong Wang
716,430US$248.7m-4.35%no data
0.51%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
566,355US$196.6m8.65%0.04%
0.45%
Artal Group S.A.
492,990US$171.1m-3.33%3.39%
0.37%
Bosera Asset Management Co., Ltd.
414,640US$143.9m0%1.16%
0.33%
SDIC Chuangyi Industry Fund Management Co., Ltd.
368,385US$127.9m0%8.98%
0.33%
Guangzhou Economic Technology Development Zone Management Committee
368,385US$127.9m0%no data
0.33%
Baillie Gifford & Co.
365,526US$126.9m-0.88%0.06%
0.32%
Geode Capital Management, LLC
355,084US$123.3m1.33%0.01%
0.32%
UBS Asset Management AG
351,733US$122.1m15.5%0.01%
0.31%
Robert W. Baird & Co. Incorporated
342,922US$119.0m0.14%0.18%
0.31%
Wanjia Asset Management Co., Ltd.
339,590US$117.9m0%3.48%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/06 18:02
End of Day Share Price 2025/11/10 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BeOne Medicines AG is covered by 72 analysts. 35 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tianli WenAletheia Analyst Network Limited
Brian SkorneyBaird
Etzer DaroutBarclays